Company Filing History:
2 out of 1,746 
2 out of 223 
2 out of 932 
Years Active: 2013-2016
Title: Howard Feldman: Innovator in Dementia Detection and Treatment
Introduction
Howard Feldman is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of neurodegenerative disorders, particularly in the detection and treatment of dementia. With a total of 2 patents, Feldman's work is paving the way for advancements in medical research and treatment options.
Latest Patents
Feldman's latest patents focus on methods and materials for detecting mutations linked to dementia. One of his key innovations involves detecting one or more mutations within PGRN nucleic acid. This patent also provides methods for assessing the level of progranulin expression. Furthermore, his work includes methods for treating mammals with neurodegenerative disorders, such as dementia. Specifically, he has developed techniques for increasing PGRN polypeptide levels in mammals and identifying agents that can enhance these levels.
Career Highlights
Throughout his career, Feldman has worked with esteemed organizations, including the Mayo Foundation for Medical Education and Research and Vib Vzw. His experience in these institutions has allowed him to collaborate with leading experts in the field, further enhancing his contributions to medical research.
Collaborations
Feldman has collaborated with notable colleagues, including Michael L. Hutton and Matthew Charles Baker. These partnerships have played a crucial role in advancing his research and innovations.
Conclusion
Howard Feldman's work in the detection and treatment of dementia represents a significant advancement in medical science. His innovative patents and collaborations highlight his commitment to improving the lives of those affected by neurodegenerative disorders.